Vaccination
Participants were vaccinated against SARS-Cov-2 as part of the Dutch national vaccination campaign. Patients who were eligible for early vaccination, because of high age or occupation in healthcare, received two mRNA-BNT162b2 vaccinations (COMIRNATY, 